Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

2018 Advancements in the Protein Targets Discovery Market - ResearchAndMarkets.com

Research and Markets
Posted on: 19 Jan 18

The "Advancements in Protein Targets Discovery" report has been added to ResearchAndMarkets.com's offering.

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across new technologies enabling the discovery of novel protein targets. The service encompasses innovations enabling protein target discovery, complement system activation, allosteric protein modulation, protein therapeutics, and targeted antibody treatments. Additionally, this TOE provides analysis of clinical trial studies for protein therapies.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain.

Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

Key Topics Covered:

  1. Accelerating Protein Target Discovery via Novel Screening Platform
  2. Pro-inflammatory Protein Targets Activating the Complement System
  3. Antibody Discovery Against Membrane Protein Targets
  4. Re-engineering Drug Discovery Approach to Address Neurodegenerative Disorders
  5. New Drug Sites for Allosteric Modulation of Proteins
  6. Protein Therapeutics for Treatment of Multiple Cancer Indications
  7. Plasma-derived Protein Therapeutics for Preventing Lung Transplantation Rejection
  8. Monoclonal Antibody for Bladder Cancer and Achondroplasia
  9. Therapeutic Protein for Rapidly Restoring Blood Clotting
  10. Summary of Recent Clinical Trials for Protein Therapeutics
  11. Industry Interactions

For more information about this report visit https://www.researchandmarkets.com/research/cjflqg/2018_advancements?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180119005453/en/

Business Wire
www.businesswire.com

Last updated on: 19/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.